Leucovorin modulation of 5-iododeoxyuridine radiosensitization: A phase I study

Clinical Cancer Research

Volumn 2, Issue 8, 1996, Pages 1299-1305

  McGinn, Cornelius J ^a,b   Kunugi, Keith A ^b   Tutsch, Kendra D ^b   Feierabend, Christine ^b   Alberti, Dona ^b   Lindstrom, Mary J ^b   Wilding, George ^b   Arzoomanian, Rhoda Z ^b   Kinsella, Timothy J ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLINIC ACID; IDOXURIDINE;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; FEMALE; GASTROINTESTINAL TUMOR; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER METASTASIS; MALE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RADIOSENSITIZATION; TREATMENT PLANNING;

ADULT; AGED; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; IDOXURIDINE; LEUCOVORIN; MALE; MIDDLE AGED; RADIATION-SENSITIZING AGENTS;

EID: 0029781033     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Wingo, P. A., Tong, T., and Bolden, S. Cancer statistics, 1995. CA Cancer J. Clin., 45: 8-30, 1995.
2. Suit, H. D., and Westgate, S. J. Impact of improved local control on survival. Int. J. Radiat Oncol. Biol. Phys., 12. 453-445, 1986.
3. Weiss, L., Grundmann, E., Torhorst, J., Hartveit, F , Moberg, I., Edder, M., Fenogolio-Preiser, C. M., Napier. J., Horne, C. H. W., Lopez, M. J., Shaw-Dunn, R. I., Sugar, J., Davies, J. D., Day, D. W., and Harlos, J. P., Haematogenous melaslatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J. Pathol., 150: 195-203, 1986.
4. Niederhuber, J. E., and Ensminger, W. D. Treatment of metastatic cancer to the liver. In: V. T. Devita, S. Hellman, and S. A. Rosenberg (eds.), Cancer: Principles and Practice of Oncology, pp. 2201-2225. Philadelphia: J. B. Lippincott Co., 1993.
5. Hellman, S., and Weichselbaum, R. R. Oligometastases. J. Clin. Oncol., 13: 8-10, 1995
6. Pu, A. T., Robertson, J. M., and Lawrence, T. S. Current status of radiation sensitization by fluoropyrimidines. Oncology, 9: 707-714, 1995.
7. Robertson, J. M., Lawrence, T. S., Walker, S., Kessler, M L., Andrews, J. C., and Ensminger, W. D. The treatment of colorectal liver metastases with conformal radiation therapy and regional chemotherapy. Int. J. Radiat. Oncol. Biol. Phys , 32: 445-450, 1995.
8. McGinn, C. J., and Kinsella, T J. The clinical rationale for S-phase radiosensitization in human tumors. Curr. Probl. Cancer, 17: 275-321, 1993.
9. Levin, V. A., Prados, M. D., Wara, W. M., Davis, R. L., Gutin. P. H., Phillips, T. L., Lamborn, K., and Wilson, C. B. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine and vincristine for the treatment of anaplastic gliomas. Int. J. Radiat. Oncol. Biol. Phys., 32: 75-83, 1995.
10. Sullivan, F. J., Herscher, L. L., Cook, J. A., Smith, J., Steinberg, S. M., Epstein, A H., Oldfield. E. H., Goffman, T. E., Kinsella, T. J., Mitchell, J. B., and Glatstein, E. National Cancer Institute (Phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododexoyuridine: encouraging results in anaplastic astrocytoma. Int. J. Radiat. Oncol. Biol. Phys., 30: 583-590, 1994.
11. Urtasun, R. C., Kinsella, T. J., DelRowe, J., Farnan, N., Lester, S., and Fulton, D. S. Survival improvement in anaplastic astrocytoma, combining external radiation with halogenated pyrimidines. Final report of RTOG 86-12, Phase I-II study. Int J. Radiat. Oncol. Biol. Phys., in press, 1996.
12. Miller, E. M., Fowler, J. F., and Kinsella, T. J. Linear-quadratic analysis of radiosensitization by halogenated pyrimidines. I. Radiosensitization of human colon cancer cells by iododeoxyuridine. Radiat. Res., 131, 81-89, 1992.
13. Lawrence, T. S., Davis, M A., McKeever, P. E., Maybaum, J., Stetson, P. L., Normolle, D. P , and Ensminger, W. D. Fluorodeoxyuridine-mediated modulation of iododeoxyuridine incorporation and radiosensitization in human colon cancer cells in vitro and in vivo. Cancer Res., 51: 3900-3905, 1991.
14. Garrett, C., Wataya, Y., and Santi, D. V. Thymidylate synthetase. Catalysis of dehalogenation of 5-bromo and 5-iodo-2′-deoxyuridylate. Biochemistry, 13: 2798-2804, 1979.
15. Moran, R. G. Leucovorin enhancement of the effects of the fluoropyrimidines on thymidylate synthase. Cancer (Phila.), 63: 1008-1012, 1989.
16. Greene, R. F., and Collins, J. M. Effects of leucovorin on idoxuridine cytotoxicity and DNA incorporation. Cancer Res., 50. 6652-6656, 1990.
17. Miller, E. M., Kunugi, K. A., and Kinsella, T. J. Effects of 5′-aminothymidine and leucovorin on radiosensitization by iododeoxyuridine in human colon cancer cells. Clin. Cancer Res., 1: 407-416, 1995.
18. Maehara, Y., Nakamura, H., Nakane, Y., Kawai, K., Okamoto, M., Nagayama, S., Shirasaka, T., and Fujii, S. Activities of various enzymes of pyrimidine nucleotides and DNA syntheses in normal and neoplastic human tissues. Gann, 73: 289-298, 1982.
19. Speth, P. A., Kinsella, T. J., Chang, A. E., Klecker, R. W., Belanger. K., and Collins, J. M. Selective incorporation of iododeoxyuridine in DNA of hepatic metastases versus normal human liver. Clin. Pharmacol. & Ther., 44, 369-375, 1988.
20. Knol, J. A., Walker, S C., Robertson, J M., Yang, Z., DeRemer, S., Stetson, P L., Ensminger, W. D., and Lawrence, T S. Incorporation of 5-bromo-2′-deoxyuridine into colorectal liver metastases and liver in patients receiving a 7-day hepatic arterial infusion. Cancer Res., 55: 3687-3691, 1995.
21. Kinsella, T. J., Collins, J., Rowland, J., Klecker, R. J., Wright, D., Katz, D., Steinberg, S. M., and Glatstein, E. Pharmacology and Phase I/II study of continuous intravenous infusions of iododeoxyuridine (IdUrd) and hyperfractioned radiotherapy in patients with glioblastoma multiforme. J. Clin. Oncol., 6: 871-879, 1988.
22. Shanahan, T. G., Mehta, M. P , Bertelrud, K. L., Buchler, D. A., Frank, L. E., Gehring, M. A., Kubsad, S. S., Utrie, P. C., and Kinsella, T. J. Minimization of small bowel volume within treatment fields utilizing customized "belly boards." Int. J. Radiat. Oncol. Biol. Phys., 19: 469-476, 1990.
23. Belanger, K., Klecker, R. W., Rowland, J , Kinsella, T. J., and Collins, J. M. Incorporation of iododeoxyuridine into DNA of granulocytes in patients. Cancer Res., 46: 6509-6512, 1986.
24. Kunugi, K. A., Vazquez-Padua, M. A., Miller, E. M., and Kinsella, T. J Modulation of IdUrd-DNA incorporation and radiosensitization in human bladder carcinoma cells. Cancer Res., 50: 4962-4967, 1990.
25. Remick, S. C., Benson, A. B., Weese, J. L , Willson, J. K. V., Ramirez, G., Wirtanen, G. W., Alberti, D. A., Nieting, L. M., Tutsch, K. D., Fischer, P. H., and Trump, D. L. Phase I trial of hepatic artery infusion of 5-iodo-2′-deoxyuridine and 5-fluorouracil in patients with advanced hepatic malignancy: biochemically based combination chemotherapy. Cancer Res., 49: 6437-6442, 1989.
26. Lawrence, T. S., Ten Haken, R. K., Kessler, M. L., Robertson, J. M., Lyman, M. T., LaVigne, M. L., Duross, D. J., Brown, M. B., Andrews, J. C., Ensminger, W. D., and Lichter, A. S. The use of 3-D dose volume analysis to predict radiation hepatitis. Int. J. Radiat. Oncol. Biol. Phys., 23: 781-788, 1992.
27. Speth, P. A., Kinsella, T. J., Chang, A. E., Klecker, R. W., Belanger, K., Smith, R., Rowland, J., Cupp, J. E., and Collins, J M. Iododeoxyuridine (IdUrd) incorporation into DNA of human hematopoietic cells, normal liver and hepatic metastases in man: as a radiosensitizer and as a marker for cell kinetic studies. Int. J. Radiat. Oncol. Biol. Phys., 16: 1247-1250, 1989.
28. Klecker, R. W., Jenkins, J. F., Kinsella, T. J., Fine, R. L , Strong, J. M., and Collins, J. M. Clinical pharmacology of 5-iodo-2′-deoxyuridine and 5-iodouracil and endogenous pyrimidine modulation. Clin. Pharmacol. & Ther., 38: 45-51, 1985.
29. Morgan, R., Klevecz, R., Doroshow, J. H., Newman, E., Carroll, M., Coluzzi, P., Leong, S., Shibata, S., Chow, W., Vasilev, S., McGonigle, K., Margolin, K., Somlo, G., Raschko, J., Tetef, M., Hamasaki. V., Wagman, L., Paz, B., Yen, Y., Akman, S., and Ahn, C Effect of intravenous calcium leucovorin on tumor cell incorporation of intraperitoneal iododeoxyuridine: flow cytometric analysis (Abstract). Proc. Am. Soc. Clin. Oncol. Annu. Meet., 14: 157, 1995.
30. Speth, P. A., Kinsella, T. J., Belanger, K., Klecker, R. W., Smith, R., Rowland, J. B., and Collins, J. M. Fluorodeoxyuridine modulation of the incorporation of iododeoxyuridine into DNA of granulocytes: a Phase I and clinical pharmacological study. Cancer Res., 48: 2933-2937, 1988.
31. Swain, S. M., Lippman, M. E., Egan, E. F., Drake, J. C., Steinberg, S. M., and Allegra, C. J. 5-Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer. J. Clin. Oncol., 7: 890-899, 1989.
32. Chu, E., Zinn, S., Boarman, D., and Allegra, C. J. The interaction of γ-interferon and 5-fluorouracil in the H630 human colon carcinoma cell line. Cancer Res., 50: 5834-5840, 1990.
33. Sotos, G. A., Grogan, L., and Allegra, C. J. Preclinical and clinical aspects of biochemical modulation of 5-fluorouracil. Cancer Treat. Rev., 20: 11-49, 1994.
34. Moertel, C. G., Gunderson, L. L., Mailliard, J. A., McKenna, P. J., Martenson, J. A., Burch, P. A., and Cha, S. S. Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. J. Clin. Oncol., 12: 21-27, 1994.
35. Jackman, A. L., Taylor, G A., Gibson, W., Kimbell, R., Brown, M., Calvert, A. H., Judson, I. R., and Highes, L. R. ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study. Cancer Res., 51: 5579-5586, 1991.
36. Pressacco, J., Hedley, D. W., and Erlichman, C. ICI D1694 and idoxuridine: a synergistic antitumor combination. Cancer Res., 54: 3772-3778, 1994.
37. Glennon, M. C., Johnston, P. G., and Kinsella, T. J. ZD 1694 (Tomudex) modulation of 5-iododeoxyuridine incorporation into cellular DNA. Proc. Am. Assoc. Cancer. Res., 50: 612, 1995.
38. Lawrence, T. S., Davis, M. A., Stetson, P. L., Normolle, D. P., Maybaum, J., and Ensminger, W. D. Kinetics of bromodeoxyuridine elimination from human colon cancer cells in vitro and in vivo. Cancer Res., 54: 2964-2968, 1994.
39. Rodriguez, R., Ritter, M. A., Fowler, J. F., and Kinsella, T. J. Kinetics of cell labeling and thymidine replacement after continuous infusion of halogenated pyrimidines in vivo. Int. J. Radiat Oncol. Biol. Phys., 29: 105-113, 1994.
40. Robertson, J. M., Sondak, V K., Weiss, S. A., Sussman, J. J , Chang, A. E., and Lawrence, T. S. Preoperative radiation therapy and iododeoxyuridine for large retroperitoneal sarcomas. Int. J. Radiat. Oncol. Biol. Phys , 31: 87-92, 1995.